Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:6 Number:29 ISSN#:2564-2537
RCT
ACE Report #11846
Ace Report Cover Shoulder & Elbow

COA/ICORS2019: Adjuvant microfracture does not improve outcomes of arthroscopic rotator cuff repair


How to Cite

OrthoEvidence. COA/ICORS2019: Adjuvant microfracture does not improve outcomes of arthroscopic rotator cuff repair . ACE Report. 2019;8(6):29. Available from: https://myorthoevidence.com/AceReport/Report/11846

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Autologous Stem Cell Augmentation in Arthroscopic Cuff Repair: a Prospective Randomized Controlled Trial

Contributing Authors: T Zhang P Lapner L Howard O Laneuville HK Uhthoff J Pollock S Ruggiero G Trudel

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

Patients scheduled for arthroscopic rotator cuff repair were randomized to either percutaneous microfracture of the supraspinatus footprint or needling of the peripheral tendon edges (control) at 5-7 days prior to repair. Patients were assessed for functional outcome and tendon healing over the first 24 months after surgery. Results demonstrated no significant differences between groups in Western...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.